Would you recommend hypofractionated salvage or adjuvant prostate XRT in the COVID setting?  

The short answer is no. It's getting harder to justify recommending adjuvant RT these days in light of the recently published randomized trials and meta-analysis showing no benefit to adjuvant over very early salvage. I would monitor patients in this category. As for salvage, unlike primary RT, the...